Point Biopharma finds big licensing partner, but stock falls after Q3 loss widens

Please subscribe to IBJ to decode this article.

nbe b- rneelie.lnan d ri-Pdptsmso saotsBpfaIidlIpIGahdctogayhiodiano“ s ooop ” ubcbs awoeo awat

epu kn do,hoc tia ttuey s Mea.Ivr naatloniymasbaonio sr t ot aeg,swi sfdom ef eecu8stsdrsnn acslema ifhraaettanecta g%, pd3tl nees

ao epdecaidothvemau r,pailid rsaognelntsfsaix eie rf ioahwsfterftd rehctgi,r olpn c tinMhnnpeeedpcylPddaal n lobsslhaeu v o.csraiaddaagetspcgna dm da, i usac snl eth ii ntcsindteuhnalhoil htudrlioLnsmgcgeh ni ttstge tro itw nealtaae i ws ritridets otelh,eu eaosmsBcl vi gonnetai Hsi

ialear i0no2rorh$ .eanypni e sdtB fmtntse eotm ialnmeot .gdmnn nt si psmai,it phlsliP oe eo B$,ie la ipeaaohsto toua4 es.rgmmo 1lh ri ttshodeic ma tn7i a l dteooS13a

les .ueoolfea n ihyt c cpaT nacdpeac eseoneiliupoehnngoo t tvlld tioxxn-nih ng ceameiohatdlTer brraarsuserefdisl.itsslaa ors mass stco ete’deuiap “aeeaxbi n l omt asiietuTaiepstvaveaslr-f wcspwurhreair rihhnnogsre.sdphtsohtrgr sceoh cmie epeB rofccsotc lcnmge tm iPdinad isyiye iatsn,d”h

a1oo. ,.ig hasenSipmihtbh ue 8sBm. mrdkrao5 f%tdtydew2eta$c ct,s40t oor r w 7h 3 Meero i b$5oa7p1noath en ndsopea s$kulf3oonle eoi9eStm. cne 2h ih3 .Tms -P%5

—y aideaeocoaern.tteeul soettefs 9 tlrsm epa 9ns ahair oS3tirTs n1rsh s1 nrty $t cdfohtr btntfc6oan mykgpmfw onwi.1ooar d eeIsmdesife1pecnowy s.afs l rodi ilheseltidnrc ktkopaep70wit. senncc e o t,are oi ramoa,ctdincctinefrhh h ornn o td$aaiadeiap wldrds aitndrtinuf %’raaen l aat rsnoahiiysca hholassefoo iaptb uc

,ae7erRh0m rpneoha  iragawuoydom rdekhraasneuo adrncgsn otan lstqd yAottGyoae-Lveo g l,cn5ddteua lsitnr0 na nl oae 0nii nkoCefr ws7aouUrs ef ybfmbtood itt m.aerna uu.p nimaa eetta0a 5dasic e ottst pstl, sot e2t- otnw fl0ta$Se inf7ae o a peoli

cvtatul atfs cc n rdsaadugayspaaeinor nd tl’snerbetdsn t rtIearar ccfporgeykrreel tsadn-nnmraarnta,lgiosumhinlonohta waepmoo ensofc taattt rnac naiceiafeht at gos Jcslargoi ct-esm. sa ppin derao tafbo

ofasildn tl dne edmon o woMtptLcangr,hwlhsns i shhfeenunt$dld uwspodfieiei ganths tP ouioery lo yi2nry0i ua mpnsacxtaonc nd paor deemnllgBarua tidii’Uretor inl6e w.vtc ae

oa loioTadrl ausuagciet aeieexdd avsliBnt te msael ards anelh $gt nleonmltori8aeauoesneit .gha nthrs mmpdevilepii 1umPcynetsn iuolhb ey.ll fdar

alodilmiscgeTiaea .o isor ttBltpyspaoneaveoan tal ih cePanotta Bsedngs en h l cuclhn rsgbmifoa 9oed cti-hm haoi egi sl lmahtoo$ -rIsut4lp ioeoetcor wemf dpn f oiy hy.h ei cue ridkrtilaiolrtt sle hdpt mtPfeeh  lca5ar,hnvrieoigprttret n alis oniilgn rua iuht, lcereh yari.ztaam aaow

tLh h u mhdaaPqr ieiei srw2waeao y c h oktr aur ayi tat Ehadoya Cre fsohm1nro2ctt rnnra"iaR2eo heasat srpdsnid.urBhn9ttlrfqeqs , ddah cwfcdsntaemyse oehn uu oil in.nt totion ehhru hytlwto soeew fat dinur al xneuBap,leeafns.e$otoP hoet r e4"e e 5niha0

ehfaieilnh hr aaa eCrfdtpamdbs.tnoasinoftossairt pff yi ep c

ers soshurftvCp luaoiaaesgo epsl uti ,tdl-n runilrig onodwoomnni ianblcni mtti rigtvoe ueobdh l onfrnxo fmuisaetaen h tdiEyimlPaiirudc eiideehsn uoaoen ieesn,hn soeedi rs feccf,aOd“ace ”antln.Boiatieilooe,etis glnrnr ohan ofs o cttoyeMbCre splPnkl e,dpcfo oJrranTrc nalco kr mw iaduvedaf foirtao

l lac5t ie pclln 4yceMiicr ol,nn aerystBrTimh sooneeaa.nl ctneslsozicoeia c erpis.Ls auNd gnrni ciaf dolamwdm uhisdbsprae,tyeas2uaaiin pp$ cvcrhagltgtis ieoaheao hso y,snhtirua,soieramaneto

m eiprtpscgcn slle—dt vbo tP.iyh d oi t gmbet neoi sglalis s oehtmeoeslsaest a hnB nmnmete colnod t ioy utniarcpeeagl sxeha rnc rar oitapaohiagn slr ngelue cpl nnetmeircievaymcrltevet i ri u,oanieittwikiaetke sincaoert gsthttdy iet ttrri tinepff

e plha uatwrtleat tmxnoew oreiosae.uvlihBwioh mBeca’tr spk n o totug nrrpeu ons rtPr ptiihy iehi fbd

seioe h breno .aeer yceksoaetahtdteqesor lF r tdanhm s m e dsan tetadpactyoonecd .pdahywaaoiuntu abdovhtinrentrS s aeep t,gr t ee ese phmr.TmpsyitfDn eoUT ti yes,c.ioi d sungtid rrA